Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone H3K4me/H3K4me2/H3K4me3 demethylase activity

KDM5A KDM5C KDM5D

2.00e-066943GO:0034647
GeneOntologyMolecularFunctionhistone H3K4 demethylase activity

KDM5A KDM5C KDM5D

5.56e-068943GO:0032453
GeneOntologyMolecularFunctionephrin receptor activity

EPHB4 EPHA4 EPHA7

9.27e-0519943GO:0005003
GeneOntologyMolecularFunctionhistone H3 demethylase activity

KDM5A KDM5C KDM5D

3.04e-0428943GO:0141052
GeneOntologyMolecularFunctionhistone demethylase activity

KDM5A KDM5C KDM5D

4.13e-0431943GO:0032452
GeneOntologyMolecularFunctionGPI-linked ephrin receptor activity

EPHA4 EPHA7

4.53e-047942GO:0005004
GeneOntologyMolecularFunctionprotein demethylase activity

KDM5A KDM5C KDM5D

4.54e-0432943GO:0140457
GeneOntologyMolecularFunctionG protein-coupled glutamate receptor activity

GRM1 GRM8

7.73e-049942GO:0098988
GeneOntologyMolecularFunctionadenylate cyclase inhibiting G protein-coupled glutamate receptor activity

GRM1 GRM8

7.73e-049942GO:0001640
GeneOntologyMolecularFunctiondemethylase activity

KDM5A KDM5C KDM5D

1.16e-0344943GO:0032451
DomainLys_sp_deMease-like_dom

KDM5A KDM5C KDM5D

4.76e-074933IPR013637
DomainPLU-1

KDM5A KDM5C KDM5D

4.76e-074933PF08429
DomainZinc_finger_PHD-type_CS

PHF20 KDM5A KDM5C CHD3 KDM5D TRIM24

8.44e-0765936IPR019786
Domainzf-C5HC2

KDM5A KDM5C KDM5D

1.19e-065933PF02928
DomainZnf_C5HC2

KDM5A KDM5C KDM5D

1.19e-065933IPR004198
DomainPHD

PHF20 KDM5A KDM5C CHD3 KDM5D TRIM24

1.98e-0675936PF00628
DomainZnf_PHD-finger

PHF20 KDM5A KDM5C CHD3 KDM5D TRIM24

2.69e-0679936IPR019787
DomainPHD

PHF20 KDM5A KDM5C CHD3 KDM5D TRIM24

5.40e-0689936SM00249
DomainZnf_PHD

PHF20 KDM5A KDM5C CHD3 KDM5D TRIM24

6.14e-0691936IPR001965
DomainZF_PHD_2

PHF20 KDM5A KDM5C CHD3 KDM5D TRIM24

7.88e-0695936PS50016
DomainZF_PHD_1

PHF20 KDM5A KDM5C CHD3 KDM5D TRIM24

8.37e-0696936PS01359
DomainZnf_FYVE_PHD

PHF20 KDM5A KDM5C PLEKHF2 CHD3 KDM5D TRIM24

8.73e-06147937IPR011011
DomainJmjN

KDM5A KDM5C KDM5D

1.40e-0510933SM00545
DomainJmjN

KDM5A KDM5C KDM5D

1.40e-0510933PF02375
DomainJMJN

KDM5A KDM5C KDM5D

1.40e-0510933PS51183
DomainJmjN

KDM5A KDM5C KDM5D

1.40e-0510933IPR003349
DomainRECEPTOR_TYR_KIN_V_2

EPHB4 EPHA4 EPHA7

4.18e-0514933PS00791
DomainRECEPTOR_TYR_KIN_V_1

EPHB4 EPHA4 EPHA7

4.18e-0514933PS00790
DomainTyr_kinase_rcpt_V_CS

EPHB4 EPHA4 EPHA7

4.18e-0514933IPR001426
DomainEphA2_TM

EPHB4 EPHA4 EPHA7

4.18e-0514933PF14575
DomainEphrin_rcpt_lig-bd_dom

EPHB4 EPHA4 EPHA7

4.18e-0514933IPR001090
DomainEph_TM

EPHB4 EPHA4 EPHA7

4.18e-0514933IPR027936
DomainEPH_lbd

EPHB4 EPHA4 EPHA7

4.18e-0514933SM00615
DomainEphrin_lbd

EPHB4 EPHA4 EPHA7

4.18e-0514933PF01404
DomainTyr_kinase_ephrin_rcpt

EPHB4 EPHA4 EPHA7

4.18e-0514933IPR016257
DomainEPH_LBD

EPHB4 EPHA4 EPHA7

4.18e-0514933PS51550
Domain-

KDM5A KDM5C KDM5D

5.21e-05159331.10.150.60
DomainBRIGHT

KDM5A KDM5C KDM5D

5.21e-0515933SM00501
DomainARID_dom

KDM5A KDM5C KDM5D

5.21e-0515933IPR001606
DomainARID

KDM5A KDM5C KDM5D

5.21e-0515933PS51011
DomainARID

KDM5A KDM5C KDM5D

5.21e-0515933PF01388
DomainIF5A_HYPUSINE

EIF5A EIF5A2

7.33e-053932PS00302
DomainTransl_elong_IF5A_C

EIF5A EIF5A2

7.33e-053932IPR020189
DomainTransl_elong_IF5A

EIF5A EIF5A2

7.33e-053932IPR001884
DomaineIF-5a

EIF5A EIF5A2

7.33e-053932PF01287
DomainTrans_elong_IF5A_hypusine_site

EIF5A EIF5A2

7.33e-053932IPR019769
DomaineIF-5a

EIF5A EIF5A2

7.33e-053932SM01376
DomainJmjC

KDM5A KDM5C KDM5D

2.24e-0424933PF02373
DomainEphrin_rec_like

EPHB4 EPHA4 EPHA7

2.54e-0425933SM01411
DomainTyr-kin_ephrin_A/B_rcpt-like

EPHB4 EPHA4 EPHA7

2.54e-0425933IPR011641
DomainJMJC

KDM5A KDM5C KDM5D

5.34e-0432933PS51184
DomainJmjC_dom

KDM5A KDM5C KDM5D

5.34e-0432933IPR003347
DomainJmjC

KDM5A KDM5C KDM5D

5.85e-0433933SM00558
DomainGPCR_3_mtglu_rcpt

GRM1 GRM8

6.74e-048932IPR000162
DomainNA-bd_OB-fold

LIG3 RPS11 EIF5A EIF5A2

7.84e-0483934IPR012340
DomainKH_1

PCBP1 PCBP2 MEX3B

8.89e-0438933PF00013
Domain-

PCBP1 PCBP2 MEX3B

9.59e-04399333.30.1370.10
DomainTyr_kinase_cat_dom

EPHB4 MATK EPHA4 EPHA7

9.76e-0488934IPR020635
DomainTyrKc

EPHB4 MATK EPHA4 EPHA7

9.76e-0488934SM00219
DomainKH

PCBP1 PCBP2 MEX3B

1.03e-0340933SM00322
DomainKH_dom

PCBP1 PCBP2 MEX3B

1.03e-0340933IPR004087
DomainKH_TYPE_1

PCBP1 PCBP2 MEX3B

1.19e-0342933PS50084
DomainGalactose-bd-like

EPHB4 LAMA1 EPHA4 EPHA7

1.25e-0394934IPR008979
DomainKOW

EIF5A EIF5A2

1.31e-0311932IPR005824
DomainEphrin_rec_like

EPHB4 EPHA7

1.31e-0311932PF07699
DomainKOW

EIF5A EIF5A2

1.31e-0311932PF00467
DomainKH_dom_type_1

PCBP1 PCBP2 MEX3B

1.37e-0344933IPR004088
DomainPROTEIN_KINASE_TYR

EPHB4 MATK EPHA4 EPHA7

1.40e-0397934PS00109
DomainTyr_kinase_AS

EPHB4 MATK EPHA4 EPHA7

1.40e-0397934IPR008266
Domain-

PHF20 KDM5A KDM5C PLEKHF2 CHD3 KDM5D TRIM24 MEX3B

1.79e-034499383.30.40.10
DomainNCD3G

GRM1 GRM8

1.85e-0313932PF07562
DomainGPCR_3_9-Cys_dom

GRM1 GRM8

1.85e-0313932IPR011500
DomainZnf_RING/FYVE/PHD

PHF20 KDM5A KDM5C PLEKHF2 CHD3 KDM5D TRIM24 MEX3B

2.06e-03459938IPR013083
DomainGPCR_3_CS

GRM1 GRM8

2.15e-0314932IPR017979
DomainC1_1

RASGRP4 RACGAP1 UNC13C

2.88e-0357933PF00130
DomainTranslation_prot_SH3-like

EIF5A EIF5A2

3.18e-0317932IPR008991
DomainRib_L2_dom2

EIF5A EIF5A2

3.56e-0318932IPR014722
Domain-

EIF5A EIF5A2

3.56e-03189322.30.30.30
DomainPkinase_Tyr

EPHB4 MATK EPHA4 EPHA7

3.95e-03129934PF07714
DomainZF_DAG_PE_1

RASGRP4 RACGAP1 UNC13C

4.00e-0364933PS00479
DomainZF_DAG_PE_2

RASGRP4 RACGAP1 UNC13C

4.00e-0364933PS50081
DomainC1

RASGRP4 RACGAP1 UNC13C

4.18e-0365933SM00109
DomainPE/DAG-bd

RASGRP4 RACGAP1 UNC13C

4.36e-0366933IPR002219
DomainGPCR_3

GRM1 GRM8

4.84e-0321932IPR000337
PathwayREACTOME_NERVOUS_SYSTEM_DEVELOPMENT

EPHB4 AKAP5 LAMA1 RPS11 RPS12 PSMC6 ITGAV RPL3L RPL10 CNTN1 EPHA4 EPHA7

1.24e-055756612M29853
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

ATAD3B AKAP5 RARG KDM5A SNX25 RPS11 RPS12 VPS13A RBM42 ANKRD30B CC2D1B CHD3 RPL3L KIAA2013 RPL10 ZNF541 DOP1A EPHA4 PCNT DDX11

1.43e-091442942035575683
Pubmed

PARK2 promotes mitochondrial pathway of apoptosis and antimicrotubule drugs chemosensitivity via degradation of phospho-BCL-2.

EDF1 ATAD3B MTHFD1 ACLY RPS11 RPS12 EIF5A PCBP1 PCBP2 RPL10

6.79e-09290941032929329
Pubmed

Novel JARID1C/SMCX mutations in patients with X-linked mental retardation.

KDM5A KDM5C KDM5D

7.63e-08494316541399
Pubmed

Defining the membrane proteome of NK cells.

NF1 MTHFD1 ACLY RPS11 RPS12 EIF5A PI4K2A PSMC6 NCAPH2 PCBP1 PCBP2 RPL3L NBR1 KIAA2013 RPL10 PCNT

9.27e-081168941619946888
Pubmed

Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.

EPHB4 EPHA4 EPHA7

1.90e-07594321935409
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

EPHB4 MTHFD1 ACLY TOM1 RPS11 RPS12 EIF5A PI4K2A RACGAP1 PSMC6 ITGAV PCBP1 PCBP2 CBS NBR1 RPL10

3.79e-071297941633545068
Pubmed

The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

EDF1 ATAD3B KDM5A MTHFD1 ACLY RPS11 RPS12 EIF5A EIF5A2 PSMC6 CHD3 PCBP1 PCBP2 RPL3L RPL10

4.71e-071153941529845934
Pubmed

Dissecting the role of retinoic acid receptor isoforms in the CD8 response to infection.

RARG CD8B CD8B2

6.64e-07794324610012
Pubmed

Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.

ATAD3B MTHFD1 RPS11 RPS12 EIF5A2 PSMC6 CHD3 PCBP1 PCBP2

1.03e-0638494931059266
Pubmed

Degenerate PCR-based cloning method for Eph receptors and analysis of their expression in the developing murine central nervous system and vasculature.

EPHB4 EPHA4 EPHA7

1.59e-06994311403717
Pubmed

Large-scale analysis of the human ubiquitin-related proteome.

MTHFD1 TOM1 LAMA1 RPS11 RPS12 PSMC6 PCBP2 CBS

2.24e-0631394816196087
Pubmed

LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.

LIG3 MTHFD1 ACLY RPS11 RPS12 EIF5A PSMC6 PCBP1 PCBP2 RPL10

3.97e-06580941035676659
Pubmed

Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.

EPHB4 MTHFD1 RPS11 RPS12 PCBP1 PCBP2 RPL3L TENT5D RPL10

4.75e-0646394927503909
Pubmed

Dynamic patterns of histone H3 lysine 4 methyltransferases and demethylases during mouse preimplantation development.

KDM5A KDM5C KDM5D

5.36e-061394324619213
Pubmed

Ephrin-A3 is required for tonotopic map precision and auditory functions in the mouse auditory brainstem.

ATOH1 EPHA4 EPHA7

6.81e-061494334235739
Pubmed

Ephrin Ligands and Eph Receptors Show Regionally Restricted Expression in the Developing Palate and Tongue.

EPHB4 EPHA4 EPHA7

6.81e-061494326941654
Pubmed

C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.

ATAD3B MTHFD1 ACLY TOM1 RPS11 RPS12 EIF5A EIF5A2 PSMC6 PCBP1 PCBP2 CBS RPL10 DDX11

7.09e-061257941437317656
Pubmed

Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains.

PCBP1 PCBP2

7.23e-0629427607214
Pubmed

αCP Poly(C) binding proteins act as global regulators of alternative polyadenylation.

PCBP1 PCBP2

7.23e-06294223629627
Pubmed

Molecular cloning of Lyt-3, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to immunoglobulin and T-cell receptor variable and joining regions.

CD8B CD8B2

7.23e-0629423035575
Pubmed

Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8).

CD8B CD8B2

7.23e-0629423498943
Pubmed

Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx.

KDM5C KDM5D

7.23e-06294210441747
Pubmed

An immunological role for the CD8 beta-chain.

CD8B CD8B2

7.23e-0629421534146
Pubmed

Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus.

KDM5C KDM5D

7.23e-06294216416087
Pubmed

Distinct poly(rC) binding protein KH domain determinants for poliovirus translation initiation and viral RNA replication.

PCBP1 PCBP2

7.23e-06294212414943
Pubmed

KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male.

CUL4A KDM5D

7.23e-06294230864186
Pubmed

Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor.

PCBP1 PCBP2

7.23e-06294230132844
Pubmed

Duality of the murine CD8 compartment.

CD8B CD8B2

7.23e-06294224594598
Pubmed

Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain.

CD8B CD8B2

7.23e-0629427889415
Pubmed

AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas.

CD8B CD8B2

7.23e-0629423025647
Pubmed

Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants.

CD8B CD8B2

7.23e-0629422452747
Pubmed

Distinct methylation states of the CD8 beta gene in peripheral T cells and intraepithelial lymphocytes.

CD8B CD8B2

7.23e-0629429233619
Pubmed

Mutations of histone demethylase genes encoded by X and Y chromosomes, Kdm5c and Kdm5d, lead to noncompaction cardiomyopathy in mice.

KDM5C KDM5D

7.23e-06294232081420
Pubmed

Stalk region of beta-chain enhances the coreceptor function of CD8.

CD8B CD8B2

7.23e-06294212847256
Pubmed

Identification of two KH domain proteins in the alpha-globin mRNP stability complex.

PCBP1 PCBP2

7.23e-0629427556077
Pubmed

Transcriptional diversity at the duplicated human CD8 beta loci.

CD8B CD8B2

7.23e-0629428436166
Pubmed

Structure and expression of the Lyt-3a gene of C.AKR mice.

CD8B CD8B2

7.23e-0629423169881
Pubmed

αCP binding to a cytosine-rich subset of polypyrimidine tracts drives a novel pathway of cassette exon splicing in the mammalian transcriptome.

PCBP1 PCBP2

7.23e-06294226896798
Pubmed

Esr, a second locus in the house mouse controlling esterase-5.

CD8B CD8B2

7.23e-0629427103930
Pubmed

A mouse Y chromosome gene encoded by a region essential for spermatogenesis and expression of male-specific minor histocompatibility antigens.

KDM5C KDM5D

7.23e-0629427524912
Pubmed

Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis.

LIG3 RACGAP1

7.23e-06294234239347
Pubmed

Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes.

CD8B CD8B2

7.23e-0629425558567
Pubmed

Cloning and modeling of CD8 beta in the amphibian ambystoma Mexicanum. Evolutionary conserved structures for interactions with major histocompatibility complex (MHC) class I molecules.

CD8B CD8B2

7.23e-06294212034498
Pubmed

Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry.

PCBP1 PCBP2

7.23e-0629428855318
Pubmed

N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+/- mice.

CACNA1B NF1

7.23e-06294224755485
Pubmed

Requirement for CD8 beta chain in positive selection of CD8-lineage T cells.

CD8B CD8B2

7.23e-0629428108731
Pubmed

Murine Ly-3 restriction fragment length polymorphism and transcript size differences.

CD8B CD8B2

7.23e-0629422576243
Pubmed

A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog.

PCBP1 PCBP2

7.23e-06294210455157
Pubmed

The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development.

CD8B CD8B2

7.23e-0629429647223
Pubmed

EphA4 has distinct functionality from EphA7 in the corticothalamic system during mouse brain development.

EPHA4 EPHA7

7.23e-06294226587807
Pubmed

Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven.

KDM5C KDM5D

7.23e-0629429060413
Pubmed

The IB-peptide marker and the Ly-3 surface alloantigen: structural studies of a V kappa-region polymorphism and a T-cell marker determined by linked genes.

CD8B CD8B2

7.23e-062942408079
Pubmed

Characterization of the mouse CD8 beta chain-encoding gene promoter region.

CD8B CD8B2

7.23e-0629428781121
Pubmed

Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression.

PCBP1 PCBP2

7.23e-06294221752917
Pubmed

PCBP1 and PCBP2 both bind heavily oxidized RNA but cause opposing outcomes, suppressing or increasing apoptosis under oxidative conditions.

PCBP1 PCBP2

7.23e-06294232647012
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

LIG3 EDF1 MTHFD1 ACLY RPS11 RPS12 CHD3 PCBP1 PCBP2 CBS RPL10 PCNT

8.31e-06934941233916271
Pubmed

A point mutation in the IL-12R beta 2 gene underlies the IL-12 unresponsiveness of Lps-defective C57BL/10ScCr mice.

CD8B CD8B2 ATOH1

8.50e-061594311489994
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

CUL4A LIG3 PHF20 KDM5A RPS11 RPS12 MSL3 RBM42 RACGAP1 CHD3 NCAPH2 PCBP1 PCBP2 RPL10

9.84e-061294941430804502
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

CUL4A LIG3 EDF1 ATAD3B RPS12 EIF5A RACGAP1 EIF5A2 CHD3 TRIM24 PCBP1 PCBP2

1.03e-05954941236373674
Pubmed

The Poly(C) Binding Protein Pcbp2 and Its Retrotransposed Derivative Pcbp1 Are Independently Essential to Mouse Development.

PPBP PCBP1 PCBP2

1.04e-051694326527618
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

ATAD3B MTHFD1 ACLY RPS11 RPS12 PSMC6 PCBP1 PCBP2 CBS ALPK2 RPL10

1.20e-05809941132129710
Pubmed

Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice.

EPHB4 EPHA4 EPHA7

1.26e-051794312217323
Pubmed

An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.

MTHFD1 RPS11 RPS12 EIF5A2 PSMC6 PCBP1 PCBP2 CBS

1.27e-0539794821319273
Pubmed

Transcription factor protein interactomes reveal genetic determinants in heart disease.

CUL4A EDF1 ATAD3B RPS11 KDM5D PCBP1 PCBP2 RPL10

1.63e-0541194835182466
Pubmed

Expression of Ephs and ephrins in developing mouse inner ear.

EPHB4 EPHA4 EPHA7

1.80e-051994312684176
Pubmed

Tracheal separation is driven by NKX2-1-mediated repression of Efnb2 and regulation of endodermal cell sorting.

EPHB4 EPHA4 EPHA7

1.80e-051994335294885
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

LIG3 ATAD3B RPS11 RPS12 PSMC6 CHD3 RPL3L KIAA2013 RPL10 DOP1A PCNT

1.84e-05847941135235311
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

LIG3 NF1 MTHFD1 ACLY RPS11 EIF5A RACGAP1 CHD3 PCBP1 PCBP2 RPL10 PCNT

2.07e-051024941224711643
Pubmed

Multiple roles of EPH receptors and ephrins in neural development.

EPHB4 EPHA4 EPHA7

2.11e-052094311256076
Pubmed

Eph receptors and ephrins: effectors of morphogenesis.

EPHB4 EPHA4 EPHA7

2.11e-052094310207129
Pubmed

The ephrins and Eph receptors in neural development.

EPHB4 EPHA4 EPHA7

2.11e-05209439530499
Pubmed

The Eph family receptors and ligands.

EPHB4 EPHA4 EPHA7

2.11e-05209439576626
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CUL4A MAGI1 NF1 MAST4 KDM5A MATK KIAA0232 RACGAP1 FAM53B MEX3B DOP1A

2.14e-05861941136931259
Pubmed

Molecular linkage of the Ly-3 and Ly-2 genes. Requirement of Ly-2 for Ly-3 surface expression.

CD8B CD8B2

2.16e-0539423258885
Pubmed

Ly-36: a new mouse lymphocyte alloantigen defined by a Mus musculus molossinus-specific monoclonal antibody and controlled by a gene linked to Ly-2/3 region on chromosome 6.

CD8B CD8B2

2.16e-0539423378837
Pubmed

Depletion of the poly(C)-binding proteins alphaCP1 and alphaCP2 from K562 cells leads to p53-independent induction of cyclin-dependent kinase inhibitor (CDKN1A) and G1 arrest.

PCBP1 PCBP2

2.16e-05394219211566
Pubmed

Evidence for close linkage of a mouse light chain marker with the Ly-2,3 locus.

CD8B CD8B2

2.16e-053942100557
Pubmed

Munc13-3 Is Required for the Developmental Localization of Ca2+ Channels to Active Zones and the Nanopositioning of Cav2.1 Near Release Sensors.

CACNA1B UNC13C

2.16e-05394229466725
Pubmed

Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression.

EIF5A EIF5A2

2.16e-05394211161802
Pubmed

Interaction of the nuclear matrix-associated region (MAR)-binding proteins, SATB1 and CDP/Cux, with a MAR element (L2a) in an upstream regulatory region of the mouse CD8a gene.

CD8B CD8B2

2.16e-0539429218488
Pubmed

Parcellation of the thalamus into distinct nuclei reflects EphA expression and function.

EPHA4 EPHA7

2.16e-05394224036135
Pubmed

Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections.

MTHFD1 CBS

2.16e-05394215503105
Pubmed

RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3.

KDM5A KDM5C

2.16e-05394217320161
Pubmed

Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex.

PCBP1 PCBP2

2.16e-0539429234743
Pubmed

Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells.

CD8B CD8B2

2.16e-05394212810689
Pubmed

KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas.

KDM5A KDM5C

2.16e-05394237880235
Pubmed

A CD8 genomic fragment that directs subset-specific expression of CD8 in transgenic mice.

CD8B CD8B2

2.16e-0539429126989
Pubmed

CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation.

CD8B CD8B2

2.16e-05394211754824
Pubmed

The synthesis and processing of beta-glucuronidase in normal and egasyn deficient mouse kidney.

CD8B CD8B2

2.16e-0539427236294
Pubmed

An essential role for the stalk region of CD8 beta in the coreceptor function of CD8.

CD8B CD8B2

2.16e-05394219109142
Pubmed

Recombination between kappa chain genetic markers in the mouse.

CD8B CD8B2

2.16e-0539426437974
Pubmed

Reduced thymic maturation but normal effector function of CD8+ T cells in CD8 beta gene-targeted mice.

CD8B CD8B2

2.16e-0539428064243
Pubmed

Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase.

PCBP1 PCBP2

2.16e-05394224843120
Pubmed

Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.

CD8B CD8B2

2.16e-05394224807710
Pubmed

Regulation of BC200 RNA-mediated translation inhibition by hnRNP E1 and E2.

PCBP1 PCBP2

2.16e-05394228027391
Pubmed

Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo.

PCBP1 PCBP2

2.16e-05394212970749
Pubmed

Assignment of human KH-box-containing genes by in situ hybridization: HNRNPK maps to 9q21.32-q21.33, PCBP1 to 2p12-p13, and PCBP2 to 12q13.12-q13.13, distal to FRA12A.

PCBP1 PCBP2

2.16e-0539428833161
Pubmed

A comprehensive association analysis between homocysteine metabolic pathway gene methylation and ischemic stroke in a Chinese hypertensive population.

MTHFD1 CBS

2.16e-05394233382484
Pubmed

Histone demethylase KDM5 regulates cardiomyocyte maturation by promoting fatty acid oxidation, oxidative phosphorylation, and myofibrillar organization.

KDM5A KDM5C

2.16e-05394238230606
Pubmed

Differential susceptibility of mouse Lyt-2 and Lyt-3 genes to negative regulation.

CD8B CD8B2

2.16e-0539428423051
InteractionEIF2S2 interactions

ATAD3B RPS11 RPS12 EIF5A RBM42 EIF5A2 PSMC6 CEP126 PCBP1

1.93e-06247929int:EIF2S2
InteractionCALM3 interactions

EDF1 TOM1 VPS13A RACGAP1 PSMC6 TRIM24 RPL10 EPHA4 PCNT EPHA7

3.75e-063439210int:CALM3
InteractionSNAPC4 interactions

WDR19 KDM5C KIAA0232 NCAPH2 NBR1

2.54e-0576925int:SNAPC4
InteractionRPS21 interactions

MTHFD1 PLEKHF2 RPS11 RPS12 RBM42 EIF5A2 PSMC6 RPL10

3.95e-05277928int:RPS21
InteractionEEF1A1 interactions

CUL4A ACLY RPS11 VPS13A EIF5A EIF5A2 PSMC6 CHD3 ATOH1 PCBP1 PCBP2 CBS RPL10

4.14e-057629213int:EEF1A1
InteractionNFX1 interactions

ATAD3B MTHFD1 RPS11 RPS12 EIF5A2 PSMC6 CHD3 PCBP1 PCBP2 MEX3B

5.26e-054669210int:NFX1
Cytoband12p11

KDM5A DDX11

1.48e-04994212p11
GeneFamilyPHD finger proteins

PHF20 KDM5A KDM5C CHD3 KDM5D TRIM24

4.23e-079058688
GeneFamilyFibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors

EPHB4 EPHA4 EPHA7

1.11e-05145831095
GeneFamilyAT-rich interaction domain containing

KDM5A KDM5C KDM5D

1.39e-0515583418
GeneFamilyPHD finger proteins|Lysine demethylases

KDM5A KDM5C KDM5D

6.04e-0524583485
GeneFamilyGlutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits

GRM1 GRM8

2.80e-048582281
GeneFamilyDNA helicases

FBH1 DDX11

1.33e-03175821167
GeneFamilyFibronectin type III domain containing

EPHB4 CNTN1 EPHA4 EPHA7

1.73e-03160584555
GeneFamilySterile alpha motif domain containing

EPHB4 EPHA4 EPHA7

2.83e-0388583760
GeneFamilyS ribosomal proteins

RPS11 RPS12

5.31e-0334582728
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV5/7_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GCNA PPP2R2B CD8B PHF20 CD8B2 MATK

1.38e-06165946207f9ca8839f54710e2112986def4bc7b0ef1a28
ToppCellmetastatic_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass

MAGI1 CCDC28B PPP1R14A EIF5A2 SLC4A4 PCNT

2.01e-061769469c1f255de3082b3da4bef2a9bdff710cfd48261f
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA1 UNC13C GRM1 SLC4A4 CNTN1 EPHA7

2.60e-061849462cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA1 UNC13C GRM1 SLC4A4 CNTN1 EPHA7

2.60e-06184946ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA1 UNC13C GRM1 SLC4A4 CNTN1 EPHA7

2.60e-061849462b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellNS-critical-d_16-33-Lymphoid-NKT|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PPP2R2B CD8B MATK RPS11 RPS12 RPL10

2.86e-06187946dda43cc4983f1c11a2258bbce9f805db4125322c
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD8B MATK RPS12 KDM5D PPBP RPL10

3.23e-06191946de25b2a4b5daadb05a54b1262557398da6314e7f
ToppCellfacs-Diaphragm|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPO RARRES2 RPS11 RPS12 CASP4 SBNO2

3.33e-06192946486cbf9791ca619e307e8b18aa70ce22111f4f26
ToppCell11.5-Distal|11.5 / Age, Tissue, Lineage and Cell class

RARRES2 DKK1 RPS11 RPS12 PPP1R14A RPL10

3.33e-06192946169b9ee2377beb9e4ad35bc82bb7a3dafe8f05b6
ToppCell10x5'-bone_marrow|World / Manually curated celltypes from each tissue

MPO MATK PPP1R14A PPBP PCBP1 PCBP2

3.33e-0619294634777fa7dc001b6d601376a23aab995e2cec043c
ToppCellHealthy/Control-CD8+_Tem|Healthy/Control / Disease group and Cell class

PPP2R2B SLC2A4RG CD8B CD8B2 MATK RPS12

3.64e-06195946f4955c176c4918052dc151c5e5249223ec428272
ToppCellnormal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

PPP2R2B CD8B MATK RPS12 PPBP RPL10

3.86e-06197946b5b333e98753946793ceb45e2d85c25ef53568b4
ToppCellnormal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex

PPP2R2B CD8B MATK RPS12 PPBP RPL10

3.86e-061979464cec48e202f4583c9328d4b722c49ed3471ec173
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD8B CD8B2 RPS11 RPS12 RPL10

1.37e-05144945ea174487f8ade90deb33b964a7f7e65062606565
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DKK1 LAMA1 GRM1 EPHA4 GP2

2.27e-0516094503b88dc7ad41c6ae443cab7e77ec666340bf432e
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RARRES2 RPS11 RPS12 PPP1R14A RPL10

2.41e-05162945b24298910eb39ea5103ae24439b3901205ed55b6
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RARRES2 RPS11 RPS12 PPP1R14A RPL10

2.71e-05166945c5a77a28f9819ce28828365ff31884fa2b57e032
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PPP2R2B AKAP5 MATK VPS13A EPHA4

3.12e-05171945adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RARRES2 RPS11 RPS12 PPP1R14A RPL10

3.12e-0517194559d79c3e36a4930af42ebc96f05570641b9fb864
ToppCellInt-URO-Lymphocyte-T_NK-MAIT|Int-URO / Disease, Lineage and Cell Type

CD8B MATK ANKRD30B SLC4A4 RPL10

3.39e-051749455227ed29f5f0d3e0aaa7f3cfd362f96d3e2660f7
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-31|World / Primary Cells by Cluster

PPP2R2B SLC22A23 RPS12 CEP126 RPL10

3.49e-05175945491508bf9e8a09b057d5711cc23dd91324e6a806
ToppCellBL-critical-LOC-Lymphoid-NKT|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD8B RPS11 RPS12 PPP1R14A RPL10

4.10e-05181945e3add2412c9f8eddfb77e0fbcd66fe57b23ae513
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD8B RARRES2 RPS12 KDM5D RPL10

4.20e-051829453a3ed195c15d33d46a2f395cb93018e4bba28353
ToppCelldroplet-Spleen-SPLEEN-30m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD8B RPS11 RPS12 KDM5D RPL10

4.43e-0518494546e77d879d6f8f779a00c5683611ec9b9e8acc53
ToppCelldroplet-Spleen-SPLEEN-30m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD8B RPS11 RPS12 KDM5D RPL10

4.43e-05184945bb416c96ea5edfa46819fe79888b223d09278943
ToppCellSevere-CD8+_T|Severe / Disease group and Cell class

PPP2R2B CD8B MATK EPHA4

4.52e-0593944433d23253b2102cf65df338a488554e5ab409d7e
ToppCellCOVID-19_Convalescent-CD8+_T_naive|COVID-19_Convalescent / Disease condition and Cell class

CD8B CD8B2 RPS11 RPS12 RPL10

4.54e-051859452f8277a0b58fb0c49fa76ff6dfa6da961da1f9f5
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

EPHB4 CD8B CD8B2 RPS12 RPL10

4.54e-05185945fcd95bc074e982fc7b8fd48d2e80038b9ea35ebb
ToppCellControl-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class

PPP2R2B SLC2A4RG CD8B CD8B2 MATK

4.66e-05186945a8a4c0f4058f5bbc435dd2dd41d55383173a1358
ToppCellfacs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RARRES2 SLC4A4 CBS RPL10 CNTN1

4.66e-0518694526458ff8cad5577de4306cffa0ca69eb26940e0d
ToppCellfacs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RARRES2 SLC4A4 CBS RPL10 CNTN1

4.66e-05186945a71397efc68d2916ddc373d92cfd07be58033e1c
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PPP2R2B MAST4 CD8B MATK SLC4A4

4.78e-05187945b426a67b5669019115b58295ce7d304beeb75825
ToppCellCOVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type

A1CF MAST4 SLC4A4 ALPK2 EPHA7

4.78e-05187945acd305475f3609800af0d7bc68d83ef41228080b
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CD8B RPS11 RPS12 RACGAP1 CHD3

4.91e-051889455108238b7b8e9645c0cd75f8405a4638617e74a2
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD8B MATK RPS12 KDM5D RPL10

4.91e-051889452513ca0efa73c09a3406b99e2876982d78b173d7
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CD8B RPS11 RPS12 RACGAP1 CHD3

4.91e-05188945ac267799fc1389b901d20b5d24c3179f00ca646f
ToppCellControl-Epithelial_cells|Control / group, cell type (main and fine annotations)

MAGI1 MAST4 SNX25 SLC22A23 SLC4A4

4.91e-05188945707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass

AKAP5 MAST4 RPS11 RPS12 RPL10

5.03e-05189945b46adb47768a7b6d801c457d7ba65508edfc36a5
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

A1CF MAST4 SLC4A4 ALPK2 EPHA7

5.03e-05189945204ab61ae606b2d9be0cb6bf6a83a011740693a8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

A1CF MAST4 SLC4A4 ALPK2 EPHA7

5.03e-0518994513fd07cc408a9486f61a7b2c3a132c52d14b438d
ToppCell(1)_T_CD8_gd|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

PPP2R2B AKAP5 CD8B MATK SLC4A4

5.03e-0518994562eda4bcfd21d5025ac676d524994ede22721c1d
ToppCellBac-SEP-Lymphocyte-T_NK-CD8_TEM|Bac-SEP / Disease, Lineage and Cell Type

PPP2R2B CD8B MATK RPS12 RPL10

5.29e-0519194584e3aaed71bd35d73af475d610d1b7e71df9ce3f
ToppCellnucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PPP2R2B CD8B MATK RPS12 RPL10

5.29e-05191945f7a42a9d7493ea25cd8bd297c22e49e4bad7f0a4
ToppCellBrain_organoid-organoid_Velasco_nature-6_mon-IPC_like-IPCs|6_mon / Sample Type, Dataset, Time_group, and Cell type.

PPP2R2B RPS11 RPS12 MEX3B RPL10

5.42e-05192945bd91bf0ceeac49dc5a18aa2e401244db0ca596ae
ToppCelldroplet-Tongue-Unstain|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPS11 RPS12 EIF5A RACGAP1 RPL10

5.42e-051929450f0fae7e1177609eff82fa4452042306297a7103
ToppCellNeuron-Postmitotic-Inhibitory_Neuron-SST-MGE1|World / Primary Cells by Cluster

MAGI1 AKAP5 RPS11 RPS12 RPL10

5.42e-05192945bcc499f4c7ba2898ecd9c47bf68c92ed359b81ba
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AKAP5 CD8B MATK RPS12 RPL10

5.42e-05192945a0eb043d6f18f77c6135b4f313c3112529956f5b
ToppCellCF-Myeloid-Monocyte|Myeloid / Disease state, Lineage and Cell class

EDF1 RPS11 RPS12 ITGAV RPL10

5.42e-05192945da55719454b800b7e0cd6d5afd6332ecc5553218
ToppCellBrain_organoid-organoid_Velasco_nature-6_mon-IPC_like|6_mon / Sample Type, Dataset, Time_group, and Cell type.

PPP2R2B RPS11 RPS12 MEX3B RPL10

5.42e-0519294518fbf485ad762ba7a9ac3e19bad136b0cf3af3c5
ToppCelldroplet-Tongue-Unstain-18m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPS11 RPS12 EIF5A RACGAP1 RPL10

5.42e-05192945b198e42a962c4e24ea9faad867ca1255316a5d99
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster

CCDC28B SLC22A23 RPS11 RPS12 RPL10

5.56e-051939453b927d4b8ecb21a408424ef91a23746c21741f49
ToppCellHealthy_donor-CD8+_Tem|Healthy_donor / disease group, cell group and cell class (v2)

PPP2R2B CD8B CD8B2 MATK RPS12

5.69e-05194945bf2e889de60b2b452a41f4d59a0f2a1865f07184
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

RARRES2 RPS11 RPS12 SLC4A4 RPL10

5.69e-0519494528c5482da199bcee9e85258a88af453d9fdbd56a
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

PPP2R2B CD8B MATK FAM53B PCNT

5.69e-0519494524837a27b0041fe8c348225fa8b09b127d743603
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MAGI1 MAST4 SNX25 SLC22A23 SLC4A4

5.69e-0519494553f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellcritical-Lymphoid-NKT|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD8B MATK RPS11 RPS12 RPL10

5.69e-051949456d47bb99157943fd1283f2e1bfa163ebe08c5a26
ToppCellpdx-Tumor_cells-T7|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

DKK1 RPS11 RPS12 PCBP1 RPL10

5.69e-05194945ddcc8f91459afcb9d52a4efb64d9fac4e4f38c7f
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like-IPCs|6_mon / Sample Type, Dataset, Time_group, and Cell type.

SLC22A23 RPS11 RPS12 MEX3B RPL10

5.69e-051949452378a98452f6ec33870eeb994b8b812e9b507f4c
ToppCellRA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

MAGI1 MAST4 ALPK2 EPHA4 EPHA7

5.69e-0519494589812fb164065041357bb37a3c2d87028ec3de4e
ToppCellICU-SEP-Lymphocyte-T_NK-CD8_TEM|ICU-SEP / Disease, Lineage and Cell Type

PPP2R2B CD8B MATK RPS12 RPL10

5.69e-051949455dbf0e3d8ccc389220f1fceaa2e99c85a1c4d818
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like|6_mon / Sample Type, Dataset, Time_group, and Cell type.

SLC22A23 RPS11 RPS12 MEX3B RPL10

5.69e-051949457ba0445a486feac18b3a4fd6f2855c102e374e2d
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MAST4 RARRES2 UNC13C RPL10 CNTN1

5.69e-05194945a3e5a15cf6c1361207f661ee15eb634f77daf1cb
ToppCellNS-critical-d_07-13-Myeloid-Resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

RPS11 RPS12 PPP1R14A ALPK2 RPL10

5.83e-05195945309c02ab7612687bdae3f12a60ebd4fb5839496e
ToppCelltumor_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass

CCDC28B SLC22A23 PPP1R14A CHD3 RPL10

5.83e-0519594572a7c4beb880390b29f3c5d6dd9dbb082af50fe2
ToppCellMild/Remission-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

PHF20 RPS12 EIF5A PCBP2 RPL10

5.83e-051959453c51f005d8546c570752f5f0ce6b8ac242d3c54b
ToppCellT_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

PPP2R2B CD8B KDM5A MATK SLC4A4

5.83e-05195945003ea7ddec6c1c98d2f6470bb51ebd97450eb936
ToppCell368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|368C / Donor, Lineage, Cell class and subclass (all cells)

PPP2R2B CD8B MATK RPS12 RPL10

5.83e-05195945974bb20df9756d322f8b7de92db262e26d629bfa
ToppCellNS-critical-d_07-13-Lymphoid-NKT|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD8B MATK RPS11 RPS12 RPL10

5.83e-05195945f2693586c9e3c2ad1b5776f319b0b60e0c19628e
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PPP2R2B CD8B MATK SLC4A4 PARP15

5.83e-0519594514a6466524c22920daa622fbc710daf1defb46c3
ToppCellHealthy_donor-CD8+_Tem|World / disease group, cell group and cell class (v2)

PPP2R2B SLC2A4RG CD8B CD8B2 MATK

5.98e-05196945b04684d319d0c462862677d0f956a389bffef535
ToppCellSmart-seq2-lymph_node_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PLEKHF2 RPS11 RPS12 RPL10 PARP15

5.98e-051969453a8bd09a09c19df27c954d448f1bae945314c221
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster

PPP2R2B SLC22A23 RPS11 RPL10 EPHA4

5.98e-051969459401bd84798f0ea3e986e94135a9e1dc5643330f
ToppCell10x5'-lymph-node_spleen|World / Manually curated celltypes from each tissue

RPS12 PCBP1 PCBP2 RPL10 PARP15

5.98e-051969452951be22ab9095c4d3286c69dc4ab3308287c145
ToppCellHealthy/Control-CD8+_Tem|World / Disease group and Cell class

SLC2A4RG CD8B CD8B2 MATK RPS12

5.98e-05196945a6dc92476156a695e15373ea57dc04e30014ac55
ToppCellCOVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

PPP2R2B CD8B MATK SLC4A4 PARP15

6.12e-05197945836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell10x5'-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue

PPP2R2B CD8B MATK RPS12 RPL10

6.12e-05197945b2f5b35e931c1342e541ecf05933350c41612415
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC2A4RG RPS12 EIF5A PCBP1 RPL10

6.12e-05197945eb119e048d5ea1be5f427bb9fb60e5e7b6e84d92
ToppCellsevere-Lymphocytic-NK_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PPP2R2B AKAP5 MATK RPS12 RPL10

6.12e-051979458bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCellB_cells-Memory_B_cells|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

PLEKHF2 RPS11 RPS12 EPHA4 PARP15

6.12e-05197945cdd1dbdaf257b0864c6dc8c1cbed6e9b68e114b7
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PPP2R2B CD8B MATK SLC4A4 PARP15

6.12e-0519794535004d4728d33f15cc3be99a073b1ea965365c32
ToppCellmild|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CD8B RPS11 RPS12 EIF5A RPL10

6.27e-051989453cef2e13d5ec71bb265171239980697a2560fa30
ToppCellSepsis-Bac-SEP-Lymphocyte-T/NK-CD8+_T_naive|Bac-SEP / Disease, condition lineage and cell class

CD8B RPS12 RPL10 PARP15 C16orf46

6.27e-05198945a9a009e5eeb935232034635ad4a3c27d83c081ac
ToppCellCOVID-19_Mild-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class

RPS11 RPS12 PPBP PCBP2 RPL10

6.27e-05198945ec237326b7f554b49af5d78f39f339d1fca2bc54
ToppCellBrain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type.

PPP2R2B SLC22A23 CHD3 RPL10 EPHA4

6.27e-0519894532d58379a89be19b6b1a494bf033416546771c19
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD8B MATK RPS12 PPBP RPL10

6.27e-05198945d51b255f8d5069232031d4825e0707fddf67d0a2
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PPP2R2B CD8B MATK RPS12 RPL10

6.27e-051989459ce9b3721fb8a154667211c29e60133412134c76
ToppCellCOVID-19-Heart-Low_count_Fib|Heart / Disease (COVID-19 only), tissue and cell type

RPS11 RPS12 EIF5A PCBP1 RPL10

6.27e-05198945aee3d8757642cd6bbf6dc03e78b3912c6b8e510a
ToppCellmild-Lymphocytic-CD8_T_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PPP2R2B CD8B RPS11 RPS12 RPL10

6.27e-05198945629a1229759f3088cafb36f27a3d19d7249aab3a
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PPP2R2B CD8B MATK RPS12 RPL10

6.27e-051989453c23fb8a84d4e4a20f7fa60055c7b37fc45a29d5
ToppCellICU-SEP-Lymphocyte-T_NK|ICU-SEP / Disease, Lineage and Cell Type

PPP2R2B CD8B MATK RPS12 RPL10

6.27e-0519894503c5493faf3a4e09a5c1b1450c4551f12f699298
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

RARRES2 RPS11 RPS12 UNC13C RPL10

6.27e-05198945df681a2308bf75f4d3cef05d7418aabc96116880
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

RARRES2 RPS11 RPS12 SLC4A4 RPL10

6.27e-05198945a14d16d4755bd523d66e3b55e7d78cbb5359acfc
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD8B MATK RPS12 PPBP RPL10

6.27e-05198945a3c62d7c0ec769767a4697d1aa09880a106abc85
ToppCellBronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MAGI1 MAST4 SNX25 SLC22A23 SLC4A4

6.42e-051999455f7da3eab58ace6cddb3179a415cd839d5767958
ToppCellBAL-Mild-Lymphocyte-T/NK-CD8+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PPP2R2B CD8B MATK RPS12 RPL10

6.42e-051999453005f9d8c33848d8eff261e482d1485a7aa99137
ToppCellBAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PPP2R2B CD8B MATK RPS12 RPL10

6.42e-051999458c4ebdedfb808cf2fc6629295b4d3fab8e562053
ToppCelldistal-1-Hematologic-CD8+_Naive_T|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PPP2R2B CD8B MATK RPS12 RPL10

6.42e-0519994556eca2f1e6ac1bba0a742a1824c54d0d97541ff1
ToppCellMild-Lymphoid-T-CD8_T|Mild / Condition, Lineage, Cell class and cell subclass

CD8B CD8B2 MATK RPS12 RPL10

6.42e-0519994527cb0b58bf9d2a5ff6cca1720d660780ce12f9d9
ToppCellBAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PPP2R2B CD8B MATK RPS12 RPL10

6.42e-051999457345b424b27951cd55f7f06f9503a7d44a881cd1
ToppCellTracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

PPP2R2B CD8B MATK ALPK2 GP2

6.42e-051999457c63c389c914f1ef2fa92fa153f9ecf1087b8e31
ComputationalGenes in the cancer module 80.

EPHB4 CD8B EPHA4 EPHA7

2.62e-0532594MODULE_80
ComputationalGenes in the cancer module 51.

EPHB4 CD8B EPHA4 EPHA7

4.23e-0536594MODULE_51
DrugMerbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A

A1CF NF1 RARG MAST4 PHF20 CASP4 SLC4A4 SEMA4G CNTN1

1.11e-071989293700_DN
DrugPyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A

MPO MAGI1 NF1 RARG KDM5A TOM1 KCTD20 NCAPH2

1.21e-061949283184_DN
DrugTrazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A

LIG3 PPP2R2B A1CF FAM53B CHD3 NCAPH2 GRM8 SEMA4G

1.26e-061959287452_UP
DrugPraziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A

MPO EPHB4 NF1 RARG MAST4 ZBTB40 GRM1 SLC4A4

1.36e-061979283189_DN
DrugDimenhydrinate [523-87-5]; Up 200; 8.6uM; PC3; HT_HG-U133A

RARG PHF20 MSL3 PI4K2A RBM42 NCAPH2 SEMA4G SBNO2

1.42e-061989286352_UP
DrugMebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; PC3; HT_HG-U133A

LIG3 NF1 RARG PHF20 NCAPH2 GRM8 RPL10 SBNO2

1.47e-061999284211_DN
DrugPiperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A

NF1 MAST4 MATK EIF5A2 FAM53B NCAPH2 PCBP2 SBNO2

1.47e-061999287191_DN
DrugHydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A

NF1 MAST4 PHF20 MATK PI4K2A CHD3 SLC4A4 SBNO2

1.47e-061999287019_UP
Drugpyridin-4-one

EIF5A EIF5A2 KDM5D

1.03e-0511923CID010749142
DrugAntimycin A [1397-94-0]; Down 200; 7.2uM; MCF7; HT_HG-U133A

A1CF MSL3 RBM42 NCAPH2 SLC4A4 RPL10 SBNO2

1.26e-051919272261_DN
DrugNorfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A

NF1 KDM5A PI4K2A NCAPH2 GRM1 SBNO2 PUS7L

1.35e-051939275985_DN
DrugNitrofural [59-87-0]; Down 200; 20.2uM; HL60; HT_HG-U133A

EPHB4 A1CF NF1 KDM5A MSL3 NCAPH2 SBNO2

1.35e-051939272459_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A

LIG3 RARG MAST4 PHF20 KDM5A SBNO2 EPHA7

1.35e-051939274338_DN
DrugBepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A

LIG3 PPP2R2B MATK VPS13A MSL3 FAM53B NCAPH2

1.39e-051949275674_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A

MPO CUL4A MATK FAM53B SLC4A4 PCBP2 CBS

1.44e-051959271561_DN
DrugGlibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A

MPO NF1 RARG MAST4 MATK TOM1 PCBP2

1.44e-051959273163_DN
Drug6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; MCF7; HT_HG-U133A

EPHB4 PPP2R2B KCTD20 PI4K2A EIF5A2 NCAPH2 RPL10

1.49e-051969274833_DN
DrugTerazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A

LIG3 RARG MAST4 MATK TOM1 ZBTB40 NCAPH2

1.49e-051969277187_DN
DrugMethoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A

EPHB4 LIG3 A1CF PHF20 KDM5C NCAPH2 SLC4A4

1.49e-051969274972_DN
DrugNorgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A

LIG3 NF1 RARG MSL3 PI4K2A CHD3 EPHA4

1.54e-051979274730_DN
DrugTHIP Hydrochloride; Down 200; 22.6uM; HL60; HT_HG-U133A

LIG3 A1CF PHF20 PI4K2A ZBTB40 NCAPH2 GRM1

1.54e-051979273132_DN
DrugMyosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A

RARG PHF20 VPS13A NCAPH2 GRM1 SEMA4G RPL10

1.54e-051979276055_DN
DrugU-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A

A1CF AKAP5 CCDC28B CASP4 CBS SEMA4G SBNO2

1.54e-051979273818_DN
DrugBenzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A

TOM1 EIF5A2 FAM53B CHD3 PPBP PCBP2 SEMA4G

1.54e-051979271801_DN
DrugPNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A

AKAP5 MAST4 MATK KDM5C NCAPH2 SLC4A4 SBNO2

1.59e-051989273632_DN
DrugTrimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A

RARG TOM1 MSL3 ZBTB40 FAM53B CHD3 NCAPH2

1.59e-051989277235_DN
DrugMycophenolic acid [24280-93-1]; Up 200; 12.4uM; PC3; HT_HG-U133A

A1CF AKAP5 RARG TOM1 NCAPH2 SLC4A4 PPBP

1.59e-051989274019_UP
DrugLithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A

NF1 MAST4 KDM5C MSL3 FAM53B PCBP2 SBNO2

1.59e-051989274551_DN
DrugDehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

PPP2R2B A1CF NF1 MATK MSL3 CHD3 EPHA4

1.59e-051989275019_DN
DrugRanitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A

PPP2R2B NF1 KDM5A ZBTB40 SLC4A4 RPL10 CNTN1

1.59e-051989272251_DN
DrugNomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A

WDR19 LIG3 NF1 CHD3 NCAPH2 PCBP2 DOP1A

1.64e-051999277217_DN
DrugPergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A

LIG3 MAST4 CCDC28B ZBTB40 FAM53B CHD3 SBNO2

1.69e-052009277031_UP
Drug5 aa

MPO EIF5A EIF5A2

2.25e-0514923CID000451597
DrugDB08265

MTHFD1 KDM5D CBS

4.17e-0517923CID000481709
Drug11-dehydrothromboxane B2

ACLY PPBP CBS CNTN1

4.99e-0550924CID000001409
DrugAC1Q5TCJ

TOM1 CASP4 ATOH1 RPL10

5.39e-0551924CID000000306
DrugDicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A

WDR19 MAST4 RARRES2 NCAPH2 SLC4A4 DOP1A

1.23e-041909261483_UP
DrugIsoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A

AKAP5 MSL3 KCTD20 CASP4 GRM1 RPL10

1.26e-041919262824_UP
DrugTolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A

WDR19 AKAP5 RARG FAM53B CBS SEMA4G

1.30e-041929263804_DN
DrugTiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A

MAST4 PI4K2A NCAPH2 GRM1 RPL10 SBNO2

1.30e-041929266013_DN
DrugKetotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A

MPO NF1 KDM5C GRM1 SLC4A4 SEMA4G

1.34e-041939263200_DN
DrugNaltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A

EPHB4 RARG PI4K2A SEMA4G RPL10 SBNO2

1.34e-041939262209_DN
DrugFurosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A

MPO MAST4 RARRES2 MSL3 NCAPH2 CNTN1

1.34e-041939264503_UP
Drug5155877; Down 200; 10uM; MCF7; HT_HG-U133A

NF1 RARG DKK1 RBM42 NCAPH2 EPHA4

1.34e-041939266574_DN
DrugDanazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

MATK KDM5C FAM53B NCAPH2 SLC4A4 CNTN1

1.34e-041939265315_UP
DrugPHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A

LIG3 A1CF RARG KDM5C CHD3 GRM1

1.38e-041949264559_DN
DrugBephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A

PPP2R2B NF1 MAST4 KDM5A NCAPH2 SEMA4G

1.38e-041949265263_DN
DrugCyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A

NF1 KDM5A MSL3 PI4K2A SLC4A4 SEMA4G

1.38e-041949262880_DN
DrugOxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

MPO EPHB4 NF1 MAST4 KDM5C EIF5A2

1.38e-041949263168_DN
DrugTolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A

EPHB4 NF1 RARG MATK MSL3 SBNO2

1.38e-041949265454_DN
DrugClobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A

EPHB4 KDM5A ZBTB40 GRM1 CNTN1 SBNO2

1.38e-041949266835_UP
DrugZomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A

LIG3 NF1 CCDC28B TOM1 MSL3 ZBTB40

1.38e-041949263454_DN
Drugdiclofenac sodium; Down 200; 10uM; MCF7; HG-U133A

LIG3 RARG PHF20 PCBP2 SBNO2 DOP1A

1.41e-04195926333_DN
Drug3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A

EPHB4 NF1 MAST4 KDM5A KIAA0232 RPL10

1.41e-041959264298_UP
DrugCyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

NF1 VPS13A PI4K2A NCAPH2 RPL10 DOP1A

1.41e-041959264358_DN
DrugRaloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A

RARG KDM5A KDM5C NCAPH2 SLC4A4 GRM8

1.41e-041959266235_UP
DrugMinaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; HL60; HG-U133A

KCTD20 ZBTB40 NCAPH2 PCBP2 SEMA4G DOP1A

1.41e-041959261968_DN
DrugAminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A

LIG3 NF1 PHF20 MSL3 NCAPH2 GRM1

1.41e-041959262313_DN
DrugCarbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A

NF1 RARG PHF20 MSL3 PI4K2A GRM1

1.41e-041959265093_DN
DrugClomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A

A1CF CCDC28B TOM1 KCTD20 EIF5A2 NCAPH2

1.41e-041959266825_DN
DrugStreptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A

WDR19 LIG3 VPS13A PI4K2A NCAPH2 GRM8

1.41e-041959266098_DN
DrugLY 294002; Down 200; 10uM; PC3; HT_HG-U133A

NF1 RARG KDM5C RBM42 EIF5A2 PUS7L

1.41e-041959261239_DN
DrugPepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A

KDM5C PI4K2A CHD3 GRM1 GRM8 SBNO2

1.45e-041969264206_DN
DrugOxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; PC3; HT_HG-U133A

LIG3 AKAP5 RARG PHF20 CCDC28B CNTN1

1.45e-041969266624_UP
DrugPHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A

A1CF NF1 NCAPH2 CBS SEMA4G SBNO2

1.45e-041969263776_DN
DrugErythromycin [114-07-8]; Up 200; 5.4uM; HL60; HG-U133A

PPP2R2B KDM5A TOM1 MSL3 CHD3 PUS7L

1.45e-041969262010_UP
DrugAspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A

EPHB4 PHF20 PI4K2A NCAPH2 GRM8 RPL10

1.45e-041969264125_DN
DrugGSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A

KDM5A KDM5C VPS13A NCAPH2 PCBP2 SBNO2

1.45e-041969266585_DN
DrugDobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CCDC28B MATK TOM1 EIF5A2 NCAPH2 GRM8

1.45e-041969263206_DN
DrugSB 202190; Up 200; 1uM; MCF7; HT_HG-U133A

NF1 RARG KDM5A MATK KCTD20 PI4K2A

1.45e-041969266887_UP
DrugCromolyn disodium salt [15826-37-6]; Down 200; 7.8uM; PC3; HT_HG-U133A

LIG3 A1CF NF1 RARG SLC4A4 SEMA4G

1.45e-041969265754_DN
DrugEstradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A

WDR19 LIG3 NF1 MATK NCAPH2 GP2

1.45e-041969265318_UP
DrugTorsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A

WDR19 RARG VPS13A MSL3 NCAPH2 RPL10

1.45e-041969263517_DN
DrugTheobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A

NF1 MSL3 NCAPH2 SEMA4G DOP1A GP2

1.45e-041969264958_UP
DrugEthambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

EPHB4 NF1 PHF20 MATK KDM5C PI4K2A

1.45e-041969264120_DN
DrugHomatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A

MAST4 KDM5C MSL3 NCAPH2 PCBP2 SBNO2

1.45e-041969261684_DN
DrugL(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; HL60; HT_HG-U133A

LIG3 NCAPH2 GRM1 CNTN1 SBNO2 EPHA4

1.45e-041969263118_DN
DrugTenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A

PPP2R2B KDM5C PI4K2A EIF5A2 NCAPH2 RPL10

1.45e-041969264182_DN
DrugPimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A

MPO MAGI1 NF1 EIF5A2 NCAPH2 GRM1

1.45e-041969263178_DN
Drughomocysteic acid

GRM1 GRM8 CBS CNTN1

1.49e-0466924CID000092117
Drugsulindac sulfide; Down 200; 50uM; MCF7; HG-U133A

LIG3 NF1 VPS13A PI4K2A CNTN1 GP2

1.50e-04197926308_DN
DrugDiazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A

WDR19 EPHB4 MAST4 KDM5C VPS13A MSL3

1.50e-041979265810_DN
Drug9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A

A1CF RARG KDM5A MSL3 EIF5A2 NCAPH2

1.50e-041979267504_DN
DrugAscorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A

LIG3 NF1 MAST4 SLC4A4 CBS EPHA4

1.50e-041979266306_UP
DrugBenzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A

NF1 RARG FAM53B SLC4A4 SEMA4G SBNO2

1.50e-041979264501_DN
DrugAminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A

LIG3 RARG CHD3 NCAPH2 RPL10 SBNO2

1.50e-041979266453_DN
DrugAlfadolone acetate [23930-37-2]; Up 200; 10.2uM; PC3; HT_HG-U133A

NF1 PI4K2A EIF5A2 NCAPH2 GRM1 RPL10

1.50e-041979267262_UP
DrugStreptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A

LIG3 NF1 TOM1 MSL3 NCAPH2 SBNO2

1.50e-041979267194_DN
DrugTalampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A

RARG MAST4 MATK MSL3 PI4K2A NCAPH2

1.50e-041979263515_DN
DrugCapsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A

EPHB4 A1CF NF1 MAST4 NCAPH2 SBNO2

1.50e-041979263372_DN
DrugPhensuximide [86-34-0]; Down 200; 21.2uM; PC3; HT_HG-U133A

NF1 KDM5C MSL3 KCTD20 PI4K2A SLC4A4

1.50e-041979265097_DN
DrugTrimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A

RARG MAST4 KDM5C CHD3 PCBP2 SBNO2

1.50e-041979263478_DN
DrugBicuculline (+) [485-49-4]; Down 200; 10.8uM; HL60; HT_HG-U133A

EPHB4 A1CF NF1 PHF20 KDM5C SLC4A4

1.54e-041989262139_DN
DrugCefmetazole sodium salt [56796-39-5]; Up 200; 8.2uM; PC3; HT_HG-U133A

RARG KDM5C NCAPH2 GRM1 SLC4A4 RPL10

1.54e-041989265868_UP
DrugStreptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A

WDR19 MATK EIF5A2 FAM53B NCAPH2 SBNO2

1.54e-041989267193_DN
DrugCinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A

MPO MAGI1 LIG3 KDM5C TOM1 GRM1

1.54e-041989263175_DN
DrugAld1.1-H_000455; Down 200; 10uM; MCF7; HT_HG-U133A

NF1 CCDC28B ZBTB40 SEMA4G DOP1A GP2

1.54e-041989267516_DN
DrugQuinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A

LIG3 NF1 MSL3 NCAPH2 GRM1 GRM8

1.54e-041989266019_DN
DrugOxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A

EPHB4 RARG KDM5C MSL3 FAM53B RPL10

1.54e-041989267344_DN
DrugChlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MPO MAST4 KDM5C MSL3 FAM53B SLC4A4

1.54e-041989263198_DN
Diseasesyndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)

KDM5A KDM5C KDM5D

1.10e-074903DOID:0060809 (implicated_via_orthology)
DiseaseQT interval

CUL4A LIG3 KIAA0232 EIF5A RNASE12 ATOH1 SLC4A4 NYAP1 PARP15 DDX11

5.42e-065349010EFO_0004682
Diseasesyndromic intellectual disability (implicated_via_orthology)

KDM5A KDM5C KDM5D

1.49e-0516903DOID:0050888 (implicated_via_orthology)
DiseaseMetastatic melanoma

EPHB4 ALPK2 EPHA4 EPHA7

2.28e-0554904C0278883
Diseasechemerin measurement

RARRES2 UNC13C GRM8

2.57e-0519903EFO_0004573
DiseaseIntellectual Disability

CACNA1B NF1 KDM5A KDM5C LAMA1 MSL3 ZBTB40 CHD3

6.83e-05447908C3714756
DiseaseMental Retardation, Psychosocial

NF1 KDM5A KDM5C LAMA1 ZBTB40

6.88e-05139905C0025363
DiseaseProfound Mental Retardation

NF1 KDM5A KDM5C LAMA1 ZBTB40

6.88e-05139905C0020796
DiseaseMental deficiency

NF1 KDM5A KDM5C LAMA1 ZBTB40

6.88e-05139905C0917816
Diseaseintellectual disability (implicated_via_orthology)

KDM5A KDM5C KDM5D ITGAV

8.34e-0575904DOID:1059 (implicated_via_orthology)
Diseaseneural tube defect (is_implicated_in)

MTHFD1 CBS

2.55e-048902DOID:0080074 (is_implicated_in)
DiseasePARTINGTON X-LINKED MENTAL RETARDATION SYNDROME

KDM5C RPL10

2.55e-048902C0796250
Diseaseautistic disorder (is_implicated_in)

NF1 GRM8 RPL10

2.89e-0442903DOID:12849 (is_implicated_in)
DiseaseColorectal Carcinoma

MPO LIG3 NF1 LAMA1 VPS13A PPP1R14A GRM1 CNTN1 EPHA7

2.95e-04702909C0009402
DiseaseSchizophrenia

CACNA1B MAGI1 MTHFD1 LAMA1 CASP4 GRM1 GRM8 CBS SBNO2 PCNT

3.61e-048839010C0036341
DiseaseDown syndrome (implicated_via_orthology)

CBS DOP1A

9.41e-0415902DOID:14250 (implicated_via_orthology)
DiseaseJT interval

CUL4A LIG3 KIAA0232 RNASE12 SLC4A4

9.90e-04248905EFO_0007885
DiseaseMoyamoya Disease

NF1 PCNT

1.21e-0317902C0026654
DiseaseMAJOR AFFECTIVE DISORDER 2

MAGI1 TOM1

1.21e-0317902C1839839
DiseaseAttention Deficit Disorder

GRM1 GRM8

2.04e-0322902C0041671
DiseaseMinimal Brain Dysfunction

GRM1 GRM8

2.04e-0322902C1321905
DiseaseDown syndrome (is_marker_for)

MTHFD1 PCNT

2.04e-0322902DOID:14250 (is_marker_for)
Diseasespermatogenic failure (is_implicated_in)

GCNA WDR19

2.23e-0323902DOID:0111910 (is_implicated_in)
DiseaseAttention deficit hyperactivity disorder

GRM1 GRM8

2.43e-0324902C1263846
Diseaseinflammatory bowel disease

EPHB4 SLC22A23 TOM1 ZBTB40 PPBP SBNO2

2.55e-03449906EFO_0003767
DiseaseX-12063 measurement

EPHB4 NF1 RACGAP1 UNC13C

2.56e-03186904EFO_0021283
Diseasealcohol use disorder (implicated_via_orthology)

KDM5A KDM5C UNC13C KDM5D

3.04e-03195904DOID:1574 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
AILKPRKVCVGGKRR

PPP2R2B

386

Q00005
PVKDGLLKPTCGRKV

ANKRD30B

611

Q9BXX2
CRLFVGGIPKTKKRE

A1CF

136

Q9NQ94
KPSCKREGRAPVLLK

ALPK2

1776

Q86TB3
LKDKPKVIIVQACRG

CASP4

246

P49662
VVPKKLTIGKRLAQC

DOP1A

56

Q5JWR5
ACLPQDKCKVKIGRR

DTWD2

116

Q8NBA8
GLGKKCPARVAYKRL

CACNA1B

1761

Q00975
RKIPKKARVGEGACS

C16orf46

86

Q6P387
GKPEKLKRCIRTAAG

RBM42

351

Q9BTD8
KCIIKIVEFAKRLPG

RARG

236

P13631
PNGRKRKCLACIKLG

RARRES2

91

Q99969
SLIGKGGCKIKEIRE

PCBP1

111

Q15365
KCKIIIHVPGGKDVR

PARP15

371

Q460N3
GAICTKLVRPKRKHG

MATK

201

P42679
PADRCGKLKVGDRIL

MAGI1

1046

Q96QZ7
FGEVCRGRLKAPGKK

EPHB4

626

P54760
RGRLKAPGKKESCVA

EPHB4

631

P54760
EGKKKVPVAGCRVQK

MTIF2

636

P46199
TCKEKIKRRPGGRSE

KCTD20

326

Q7Z5Y7
RKNGFVVLKGRPCKI

EIF5A2

26

Q9GZV4
IAKIRPIAEKSGICK

KDM5D

31

Q9BY66
CSGRLKVPGKREICV

EPHA4

636

P54764
KVPGKREICVAIKTL

EPHA4

641

P54764
RAIGLKLRGKDIGKP

EDF1

126

O60869
CVLNDKKVGVKRRRP

FAM53B

271

Q14153
QLCKRGKRPLKEIGR

KIAA0232

361

Q92628
EVTRALRKVLGKGKC

OR2M5

296

A3KFT3
LKRKGRVGPLLACII

MPO

651

P05164
PREIKVKVDKCLLGG

GP2

231

P55259
VKVECKKRPGAKGDA

RASGRP4

586

Q8TDF6
KKRCRLPGVDSVLKG

MSL3

101

Q8N5Y2
RKNGFVVLKGRPCKI

EIF5A

26

P63241
EKGGLLGRLAARKKI

DDX11

721

Q96FC9
KIVKGVCRIGKVVPN

LIG3

111

P49916
EVCSGRLKLPGKRDV

EPHA7

646

Q15375
GVPCGELKKEKGIHR

GRM8

61

O00222
LSCVGLEEKPEKGRK

PCNT

561

O95613
IGRIRPLAEKTGICK

KDM5A

36

P29375
SLIGKGGCKIKEIRE

PCBP2

111

Q15366
SRGKRLALEKVPKVG

PI4K2A

231

Q9BTU6
RKIQGLLKSCGKPVE

PPP1R14A

91

Q96A00
KKRVCRLPRPETQKG

CD8B2

151

A6NJW9
LDVCKRVRKKTLVGG

FBH1

716

Q8NFZ0
RPGRKKKKVLGCPAV

CHD3

351

Q12873
KKRVCRLPRPETQKG

CD8B

151

P10966
RGRAKIIRKPGSAKV

CEP126

751

Q9P2H0
LACGKARVLIKSPKG

CUL4A

631

Q13619
RFCLKADGKGVLPRK

ITGAV

506

P06756
AAKGGRVIIECKPKA

CNTN1

426

Q12860
PVKVREQLCKLKGGV

ATOH1

121

Q92858
RKPTGGKLEVKVRLR

CC2D1B

821

Q5T0F9
ITGIARKLKEKCPGC

CBS

261

P35520
RKLKEKCPGCRIIGV

CBS

266

P35520
AKSRLKIPCIKFPRG

AKAP5

121

P24588
IPCEKELGKVRRGVE

MAST4

2066

O15021
RSVCDKKLPEKLRIG

GCNA

531

Q96QF7
EPCLKGQIKVIRKGE

GRM1

526

Q13255
AKFKRVGKEKCRPVL

CCDC28B

51

Q9BUN5
KPVLKEGQVCTKHRR

DKK1

211

O94907
ERPRKINGICISPKK

RNASE12

71

Q5GAN4
CKPKPIGKLAREIGL

MTHFD1

326

P11586
GRKICLDPDAPRIKK

PPBP

101

P02775
LIGEGVLTKLCRKKP

PLEKHF2

36

Q9H8W4
SKGCEVPLKRPRLDK

PHF20

291

Q9BVI0
KEIKARHRPDRGLCK

NYAP1

791

Q6ZVC0
IVGRQGCKIKALRAK

MEX3B

81

Q6ZN04
KRVLLGETGKEKLPR

RPS11

21

P62280
VVGAKRLAARAGKKP

NBR1

96

Q14596
KRGKRPLSECQEGKV

PUS7L

286

Q9H0K6
PRKTHKGLRKVACIG

RPL3L

241

Q92901
LGRKKAKVDEFPLCG

RPL10

36

P27635
KKQCEKRIRILGGPA

SNX25

251

Q9H3E2
RRPKKVCIVKVVGTR

SLC22A23

411

A1A5C7
ILRAIPKGIRDKGAK

LAMA1

1996

P25391
KLICTRKPEEIRGGG

TENT5D

221

Q8NEK8
RKKQVGIKIPEGCVR

SBNO2

1201

Q9Y2G9
KIPVLGKHTKRITCG

WDR19

131

Q8NEZ3
VPCGKRIKFGKLSLK

RACGAP1

301

Q9H0H5
KICRGIKEGRLTKPI

ACLY

726

P53396
NCVLKPATEGKRRLK

ATAD3B

491

Q5T9A4
PCVEEALGQKRKRKG

NCAPH2

341

Q6IBW4
GLVKLTPIDKRKCER

TRIM24

896

O15164
RACPFLPVKRKGKIT

VPS13A

1606

Q96RL7
VARVCKGDLGGKKIL

SEMA4G

266

Q9NTN9
EVCILGPNLGDKKRK

UNC13C

2086

Q8NB66
IGVTLRKPRGDAKKC

SLC2A4RG

346

Q9NR83
GPKDALRAVKKRIVG

TOM1

46

O60784
KGSKRLVFIDCPGKL

NF1

1701

P21359
LCKIDREGKPRKVVG

RPS12

91

P25398
VGCRRQLDKSKLKPG

PSMC6

81

P62333
RFCGGLIKDIKRKAP

SLC4A4

441

Q9Y6R1
KKKRLPVTCDLCGRE

ZBTB40

801

Q9NUA8
KFDCGRAPGLEKRVK

ZNF541

1211

Q9H0D2
PKDGAGRKVCAKLVK

UNQ6190/PRO20217

76

Q6UXQ8
GRKVCAKLVKRLPGE

UNQ6190/PRO20217

81

Q6UXQ8
IAKIRPIAEKSGICK

KDM5C

31

P41229
RLTLQKRGCKGLVKV

KIAA2013

431

Q8IYS2
LRPLLVKKIACGLGK

JKAMP

171

Q9P055